INVESTING IN EUROPE - SCALING IN ASIA

 

CONVERGENCE PARTNERS

Convergence Partners was formed in 2018 by experienced venture capital and operational experts with a vision to establish a venture capital firm that actively supports the internationalisation and market access of European technology innovators to large Asian markets, with a particular focus on China and India. Whereas our current investment focus is on EU HealthTech startups, Convergence is able to open its established EU-Asia cross-border acceleration platform to any Deeptech company that is keen to realise the enormous Asia market potential.

Please get in touch with us to discuss your growth and investment plans.

INVESTMENT FOCUS

Medical Devices

Diagnostics

Digital Health

KEY INVESTMENT SELECTION CRITERIA

We are interested to hear from innovative EU HealthTech companies that have commercialised their technologies and are looking to accelerate scale-up.

Key Investment Selection Criteria

  • B2B-focused HealthTech company with
    strong growth potential in Asia
  • Highly scalable, IP-driven business model
  • Commercialised product with first revenues

Typical Deal Structure

  • Significant equity minority stake
  • Ticket size up to EUR 5M initially - additional capital
    reserved for follow-on investments
  • Board representation to support management
    teams as an active sparring partner

OUR TEAM

The Convergence Team is represented in Switzerland and Germany and has additional hubs in Shenzhen, Hangzhou and Singapore to effectively support the internationalization of our portfolio companies. The investment team is supported by experienced venture partners, a top-class advisory board and leading landing & scale-up partners in Europe and Asia.

Daniel Koppelkamm
Founder, Managing Partner & Investment Committee Member
Raj Airey
Founding Partner & Investment Committee Member
Ke (Ken) Zhang
Founding Partner & Investment Committee Member
Mikael von Euw
Operating Partner
Jörg Trinkwalter
Venture Partner, Germany
Dweep Chanana
Venture Partner, Switzerland
Dr. Laura Johnson
Venture Partner, Germany
Gerard Valverde
Venture Partner, Spain
Xingyue Chen
Venture Partner, Benelux
Tal Gal On
Venture Partner, Israel
Lingxi Zeng
Venture Partner, China
Dr. Songia Wen
Venture Partner, China
Shervin Sharghy
Venture Partner, SE Asia
Prof. Erich Reinhardt
Advisor
Dr. Patrick Pfeffer
Advisor
Dr. Arvind Madan
Advisor
Dr. Renchen Liu
Advisor
Stefan Säuberlich
Investment Director
Christian Rasmussen
Analyst
Tong Zhou
Analyst

OUR TEAM

NEWS & UPDATES

Medical Valley EMN & Convergence Partners form alliance with Greenland Health.
read more

 

CP has closed an investment into Oxford University spin-out Oxford Endovascular.
read more

 

Convergence Partners is proudly supporting the leading German AI-/Digital Diagnostics conference DxPx 2020.
read more

 

STRATEGIC PARTNERS

© Copyright 2021 Convergence Partners AG. Implementation by progressio
We use cookies to enhance your experience. More info
Got it!